We examined age-related differences in the reactive and proactive use of affect regulation strategies. We collected data from 209 participants 13-80 years of age, using an experience sampling method. The most interesting finding was that, as hypothesized, compared with those under 20, adults 20 and over used the 2 strategies we focused on (i.e., problem solving and positive reappraisal) more intensely and in a reactive manner. By contrast, from the age of about 55 upward, adults were characterized by a more intensely proactive use of these strategies. Results are discussed in the light of age differences in motivation. (PsycINFO Database Record
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1037/pag0000197 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Although men and women generally receive positive and negative reactions to childhood sexual abuse (CSA) disclosure (Filipas & Ullman, 2001), negative reactions are more common (Gagnier & Collin-Vézina, 2016). Negative disclosure reactions - such as disbelieving, retaliating against, or distracting the survivor - are both prevalent and associated with poorer post-abuse recovery and well-being (Kennedy & Prock, 2018; Ullman, 2010). For male survivors in particular, the responses one receives from others following disclosure may complicate one's sense of masculinity.
View Article and Find Full Text PDFCarbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy.
Eur J Breast Health
January 2025
Department of General Surgery, Elazığ Fethi Sekin City Hospital, University of Health Sciences Turkey, Elazığ, Turkey.
Objective: Triple negative breast carcinoma (TNBC) is characterized by the absence of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 receptor expression. Carbonic anhydrase IX (CA IX) is a tumor-associated cell surface glycoprotein that is involved in adaptation to hypoxia-induced acidosis and plays a role in cancer progression. The aim of this study was to investigate CA IX expression in TNBC and its relationship with treatment effect.
View Article and Find Full Text PDFTenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial.
Stroke
January 2025
Department of Neurology, National Center for Neurological Disorders, National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China (X.C., L.H., Y.L., Yiran Zhang, X.L., S.L., L.Y., Q.D.).
Background: Whether it is effective and safe to extend the time window of intravenous thrombolysis up to 24 hours after the last known well is unknown. We aimed to determine the efficacy and safety of tenecteplase in Chinese patients with acute ischemic stroke due to large/medium vessel occlusion within an extended time window.
Methods: Patients with ischemic stroke presenting 4.
Sex-Based Differences in Endovascular Thrombectomy Outcomes for Large Ischemic Stroke: A SELECT2 Subanalysis.
Stroke
January 2025
Neurology, Stroke, University Hospital Cleveland Medical Center - Case Western Reserve University, OH. (A.O., C.S., A.S.).
Background: Several social and biological factors are shown to differentially affect stroke outcomes between men and women. We evaluated whether clinical outcomes and endovascular thrombectomy (EVT) treatment effects differed between the sexes in patients presenting with large ischemic stroke.
Methods: The SELECT2 trial (A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke) was a randomized controlled trial assessing the efficacy and safety of EVT in patients with large strokes across the United States, Canada, Europe, Australia, and New Zealand between October 2019 and September 2022.
Treatment Decision-Making Among Chinese Americans With Chronic Rhinosinusitis.
Laryngoscope
January 2025
Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles, California, U.S.A.
Objective: There has been limited research on the influence of race and ethnicity on treatment decision-making for chronic rhinosinusitis (CRS). This prospective study aims to investigate potential factors linked to treatment modality choice among patients with medically refractory CRS, distinguishing between Chinese American and non-Chinese American patients.
Methods: CRS patients with persistent symptoms despite prior medical treatment were prospectively enrolled.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!